At STADA, we follow our purpose of “Caring for People’s Health as a Trusted Partner”. In pursuit of this purpose, we are committed to further accelerating the successful trajectory of our company.
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for more than 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally.
STADA focuses on a three-pillar strategy consisting of consumer healthcare products, generics, specialty pharmaceuticals. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare brands such as Zoflora®, Snup®, Nizoral® and Grippostad® are among the top sellers in their respective product categories. In financial year 2022, STADA achieved group sales of EUR 3,797.2 million and reported earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 884.7 million. As of 31 December 2022, STADA employed 13,183 people worldwide.
